Andrew Fuller Marathon Appeal ‘AFMA’. Donation to The William Low Trust September 2022
Paul, Mark and Alison and the extended Fuller family have made a kind and large donation of £13,580.17 from their charity, the Andrew Fuller Marathon Appeal ‘AFMA’.
Paul Fuller wrote ‘Andrew Fuller was a keen sportsman and recently qualified PE teacher who collapsed whilst playing football in late October 1998. 24 hours later he had both legs amputated in an attempt to prevent a virulent cancer spreading through his body. In the weeks that followed Andrew vowed that he would compete in the London Marathon in a wheelchair. To this end, the Andrew Fuller Marathon Appeal (“AFMA”) was established but sadly the cancer was too aggressive and Andrew died on 5th December, less than 6 weeks after his diagnosis. He was 27. Following his death and a football match in his memory at Queens Park Rangers which raised more than £10,000, AFMA became a registered charity, with an objective of promoting disability sport resulting in various donations over the years. The family believe supporting The William Low Trust is a worthy use of funds not currently being actively deployed’.
It was extremely touching to hear about Andrew and the charity AFMA. We are fully aware of the impact such a huge loss of a young life has on a family and the emotional challenges it brings. Like William, he wanted to live his life which was sadly taken away far too soon from cancer.
As you know, our darling son William tragically passed away in August 2017, six weeks before his 18th birthday from Medullloblastoma brain tumours. We have commissioned a PhD student researcher at Queen Mary University Hospital, whose research is focusing on Medulloblastoma tumours that William lost his life to. This research is hoped to significantly improve treatment options for patients. We have a huge target of raising £143,000 over 4 years!
The committee for would like to thank the Fuller family again for their kind and generous donation to our charity; we will certainly put it to good use by funding the research that we have commissioned.